Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2008

View Archived Issues

New agents for treating HIV infection reported in recent patent literature

HIF prolyl hydroxylase inhibitors for anemia prepared and tested at GSK

Prevention of acute, chronic rejection of solid tissue allografts with regulatory T cells

Abbott presents fourth quarter 2007 results

Recent patents disclose novel neuropsychiatric agents

Asenapine demonstrates long-term efficacy in bipolar disorder

Generex receives Ukrainian approval for phase III clinical trial of Generex Oral-lyn

Phase II dose of E-7974 in 21-day schedule determined in solid tumor patients

No objective responses seen with tremelimumab in gastric, esophageal adenocarcinoma

Abbott and Eisai announce changes in the sales scheme for adalimumab in Japan

Arius completes pre-IND meeting with FDA for lead anticancer antibody

Arno Therapeutics completes license agreements for novel targeted cancer compounds

Nabilone improves pain, quality of life in fibromyalgia patients

Calibrant collaborates with Cleveland Clinic on brain cancer drug discovery

Derma enters phase II development for wound-healing product

FDA accepts sNDA for Fentora for management of breakthrough pain

Medivation plans pivotal confirmatory phase III Dimebon trial in AD

N30 Pharma initiates human studies with N30-201

Oncothyreon highlights corporate and clinical objectives for 2008

FDA accepts AZX-100 IND application in dermal/hypertrophic scarring

Acrux reports results for phase I fentanyl trial using metered-dose transdermal spray

FDA approves Emend for Injection as part of treatment for CINV

Neose discontinues NE-180 program

FDA approves IND for clinical phase II trial with uPA inhibitor WX-671

Serenex collaborates with NCI for small-molecule Hsp90 inhibitors in lung cancer

Peregrine opens enrollment in phase II bavituximab trial in advanced breast cancer

Acorda Therapeutics announces successful QT study of Fampridine-SR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...